Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies
暂无分享,去创建一个
J. Gabrilove | A. Shih | J. Mascarenhas | M. Kremyanskaya | M. Bar‐Natan | D. Tremblay | A. Keyzner | L. Silverman | B. Marcellino | J. Feld | S. E. El Jamal | S. Navada | Gillian Sanchez | Mikaela Dougherty | Tina Czaplinska | C. Brady